Fetal fibronectin assay may reduce management cost of preterm labour: an interval analysis.
Musaad
Samarina M A
SM
Melson
Louise C
LC
Boswell
Ross D
RD
D000328:Adult; D001681:Biological Assay; D015415:Biomarkers / Q000032:analysis; D003362:Cost-Benefit Analysis; D005260:Female; D005353:Fibronectins / Q000032:analysis* / Q000191:economics; D006023:Glycoproteins / Q000032:analysis* / Q000191:economics; D017721:Hospital Costs; D006801:Humans; D007231:Infant, Newborn; D007902:Length of Stay / Q000191:economics; D007752:Obstetric Labor, Premature / Q000191:economics* / Q000517:prevention & control; D011237:Predictive Value of Tests; D011247:Pregnancy; D011256:Pregnancy Outcome; D011296:Prenatal Diagnosis / Q000379:methods*
D015415:Biomarkers; C403421:FFN protein, human; D005353:Fibronectins; D006023:Glycoproteins